San Diego, CA, United States of America

Mark Daniels

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mark Daniels

Introduction

Mark Daniels is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of medical technology, particularly in the treatment of diabetic subjects with microvascular impairment disorders. His innovative approach has the potential to improve the quality of life for many individuals suffering from these conditions.

Latest Patents

Mark Daniels holds a patent for a method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide. This invention relates to PEGylated C-peptide derivatives that comprise at least one PEG group attached to the N-terminus. These derivatives exhibit improved pharmacokinetic and biological activity in vivo, showcasing Mark's commitment to advancing medical treatments.

Career Highlights

Mark currently works at Cebix Ab, a company dedicated to developing innovative therapies for metabolic diseases. His work at Cebix Ab has allowed him to focus on groundbreaking research that addresses critical health issues. With one patent to his name, Mark has established himself as a key player in the field of medical innovation.

Collaborations

Mark has collaborated with notable professionals in his field, including John Wahren and Sheri Barrack. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical technology.

Conclusion

Mark Daniels is a pioneering inventor whose work in the field of medical technology is making a significant impact. His innovative patent for treating diabetic subjects demonstrates his dedication to improving healthcare solutions. Through his career at Cebix Ab and collaborations with esteemed colleagues, Mark continues to push the boundaries of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…